Bio Green Energy Tech PCL (BKK:BIOTEC)

Bio Green Energy Tech PCL Statistics

Total Valuation

BKK:BIOTEC has a market cap or net worth of THB 519.07 million. The enterprise value is 988.31 million.

Market Cap	519.07M
Enterprise Value	988.31M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

BKK:BIOTEC has 3.05 billion shares outstanding.

Current Share Class	3.05B
Shares Outstanding	3.05B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	45.68%
Owned by Institutions (%)	0.02%
Float	1.06B

Valuation Ratios

The trailing PE ratio is 4.59.

PE Ratio	4.59
Forward PE	n/a
PS Ratio	0.12
PB Ratio	0.46
P/TBV Ratio	1.11
P/FCF Ratio	10.20
P/OCF Ratio	6.73
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.42, with an EV/FCF ratio of 19.42.

EV / Earnings	8.74
EV / Sales	0.23
EV / EBITDA	6.42
EV / EBIT	13.40
EV / FCF	19.42

Financial Position

The company has a current ratio of 0.55, with a Debt / Equity ratio of 0.50.

Current Ratio	0.55
Quick Ratio	0.30
Debt / Equity	0.50
Debt / EBITDA	3.67
Debt / FCF	11.07
Interest Coverage	1.65

Financial Efficiency

Return on equity (ROE) is 10.62% and return on invested capital (ROIC) is 4.14%.

Return on Equity (ROE)	10.62%
Return on Assets (ROA)	1.88%
Return on Invested Capital (ROIC)	4.14%
Return on Capital Employed (ROCE)	5.31%
Weighted Average Cost of Capital (WACC)	5.16%
Revenue Per Employee	21.48M
Profits Per Employee	562,570
Employee Count	201
Asset Turnover	1.77
Inventory Turnover	20.15

Taxes

In the past 12 months, BKK:BIOTEC has paid 10.87 million in taxes.

Income Tax	10.87M
Effective Tax Rate	8.72%

Stock Price Statistics

The stock price has decreased by -26.09% in the last 52 weeks. The beta is -0.24, so BKK:BIOTEC's price volatility has been lower than the market average.

Beta (5Y)	-0.24
52-Week Price Change	-26.09%
50-Day Moving Average	0.18
200-Day Moving Average	0.19
Relative Strength Index (RSI)	45.39
Average Volume (20 Days)	784,095

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BKK:BIOTEC had revenue of THB 4.32 billion and earned 113.08 million in profits. Earnings per share was 0.04.

Revenue	4.32B
Gross Profit	203.61M
Operating Income	73.41M
Pretax Income	124.71M
Net Income	113.08M
EBITDA	129.45M
EBIT	73.41M
Earnings Per Share (EPS)	0.04

Balance Sheet

The company has 100.63 million in cash and 563.57 million in debt, with a net cash position of -462.94 million or -0.15 per share.

Cash & Cash Equivalents	100.63M
Total Debt	563.57M
Net Cash	-462.94M
Net Cash Per Share	-0.15
Equity (Book Value)	1.13B
Book Value Per Share	0.37
Working Capital	-409.87M

Cash Flow

In the last 12 months, operating cash flow was 77.12 million and capital expenditures -26.21 million, giving a free cash flow of 50.90 million.

Operating Cash Flow	77.12M
Capital Expenditures	-26.21M
Free Cash Flow	50.90M
FCF Per Share	0.02

Margins

Gross margin is 4.72%, with operating and profit margins of 1.70% and 2.64%.

Gross Margin	4.72%
Operating Margin	1.70%
Pretax Margin	2.89%
Profit Margin	2.64%
EBITDA Margin	3.00%
EBIT Margin	1.70%
FCF Margin	1.18%

Dividends & Yields

BKK:BIOTEC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	21.78%
FCF Yield	9.81%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BKK:BIOTEC has an Altman Z-Score of 1.82 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.82
Piotroski F-Score	6